EP1798285

ALNYLAM EUROPE
Application Number
EP06025389A
Filing Date
Jan 29, 2000
Status
Revoked
Jun 28, 2019
Grant Date
Mar 15, 2017
External Links
Slate, Register, Google Patents

Biblio Summary

The patent EP1798285B1 was granted on Mar 15, 2017 by Alnylam Europe The patent is currently Revoked.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

SILENCE THERAPEUTICSDec 15, 2017ADMISSIBLE

Patent citations in opposition refer to prior patents or publications that may challenge the validity of a contested patent. These references help assess whether the invention is truly novel or overlaps with existing intellectual property.

Citation PhasePatent NumberPatent LinkCited Text
OppositionEP1798285B1
N/A
OppositionWO9932619
N/A
OppositionWO0044914
N/A
OppositionWO2004015107
N/A

Access Full Citation Information

Get a free, in-depth citation report including examiner, opposition, and international search citations.

Get Free Citation Report

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.